Zobrazeno 1 - 5
of 5
pro vyhledávání: '"Carl M. Thielmann"'
Autor:
Frederik Krefting, Elisabeth Livingstone, Wiebke Sondermann, Carl M. Thielmann, Jan‐Malte Placke, Dirk Schadendorf, Christina Polan, Peter Michael Rath, Ulrike Scharmann, Silke Uhrlaß, Pietro Nenoff
Publikováno v:
JEADV Clinical Practice, Vol 3, Iss 3, Pp 887-890 (2024)
Abstract Tinea capitis is a prevalent dermatophyte infection among German children, primarily caused by Microsporum canis, Trichophyton mentagrophytes and Trichophyton benhamiae. Other pathogens, such as T. soudanense and M. audouinii, have also been
Externí odkaz:
https://doaj.org/article/93d741d9b6b447fdb0e711e68bcdcd79
Autor:
Carl M. Thielmann, Antje Kampmeier, Alma Küchler, Martin Zenker, Ilse Wieland, Johanna Matull, Frederik Krefting, Klaus Griewank, Eva Hadaschik
Publikováno v:
JEADV Clinical Practice, Vol 1, Iss 4, Pp 416-419 (2022)
Abstract Giant congenital melanocytic naevi (CMN) are large melanocytic lesions commonly associated with neurologic abnormalities. Patients diagnosed with giant melanocytic naevi are at an increased risk of developing melanoma compared to patients wi
Externí odkaz:
https://doaj.org/article/7604a5c3f0f944a1a79aca15ca67cb6e
Autor:
Michael Weichenthal, Patrick Terheyden, Edgar Dippel, Georg Lodde, Rudolf A. Herbst, Inga Möller, Lisa Zimmer, Dirk Schadendorf, Julia Kretz, Peter Mohr, Ralf Gutzmer, Jochen Utikal, Eleftheria Chorti, Johanna Matull, Claudia Pföhler, Annette Paschen, Luisa Richter, Anne Zaremba, Philipp Jansen, Friedegund Meier, Selma Ugurel, Carl M. Thielmann, Antje Sucker, Eva Hadaschik, Jens Ulrich, Klaus G. Griewank, Alexander Kreuter, Rajmohan Murali, Elisabeth Livingstone
Publikováno v:
Eur J Cancer
Background NF1-mutated tumours represent a small subset (10–15%) of melanomas, not sufficiently analysed in large clinical cohorts. This study investigated the largest multicentre collection of NF1-mutated melanomas to date. Methods This study anal
Autor:
Georg C. Lodde, Philipp Jansen, Inga Möller, Antje Sucker, Jessica C. Hassel, Andrea Forschner, Julia Eckardt, Friedegund Meier, Lydia Reinhardt, Katharina C. Kähler, Mirjana Ziemer, Max Schlaak, Farnaz Rahimi, Kerstin Schatton, Frank Meiss, Ralf Gutzmer, Claudia Pföhler, Patrick Terheyden, Bastian Schilling, Michael Sachse, Markus V. Heppt, Anca Sindrilaru, Ulrike Leiter, Anne Zaremba, Carl M. Thielmann, Selma Ugurel, Lisa Zimmer, Eva Hadaschik, Nikolaos E. Bechrakis, Dirk Schadendorf, Henrike Westekemper, Elisabeth Livingstone, Klaus G. Griewank
Conjunctival melanoma is a rare type of ocular melanoma, which is prone to local recurrence and metastasis and can lead to patient death. Novel therapeutic strategies have revolutionized cutaneous melanoma management. The efficacy of these therapies
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::aa8938e696eecc25e7986ac159f01883
https://www.ncbi.nlm.nih.gov/pubmed/35279471
https://www.ncbi.nlm.nih.gov/pubmed/35279471
Autor:
Carl M. Thielmann, Johanna Matull, Anne Zaremba, Rajmohan Murali, Eleftheria Chorti, Georg Lodde, Philipp Jansen, Rudolf Herbst, Patrick Terheyden, Jochen Utikal, Claudia Pföhler, Jens Ulrich, Alexander Kreuter, Peter Mohr, Ralf Gutzmer, Friedegund Meier, Edgar Dippel, Michael Weichenthal, Julia Kretz, Inga Möller, Antje Sucker, Annette Paschen, Elisabeth Livingstone, Lisa Zimmer, Eva Hadaschik, Selma Ugurel, Dirk Schadendorf, Klaus G. Griewank
Publikováno v:
Eur J Cancer
Around 50% of cutaneous melanomas harbour therapeutically targetable BRAF V600 mutations. Reliable clinical biomarkers predicting duration of response to BRAF-targeted therapies are still lacking. Recent in vitro studies demonstrated that BRAF-MEK in
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::fb9b8c5654bbb782e5856928d5f19763
https://www.ncbi.nlm.nih.gov/pubmed/000791945800011
https://www.ncbi.nlm.nih.gov/pubmed/000791945800011